Orphan designation: 3-(3-(3,5-Dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid Treatment of AT

European Medicines Agency (EMA) | What's new

RSS Hunter • Jan 15, 2025